Summary
According to APO Research, The global Granisetron market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Granisetron is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Granisetron include Kyowa Kirin, Teva, Sandoz, Mylan, Fresenius Kabi, Wockhardt, Taro Pharmaceutical, Natco Pharma and Hikma Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Granisetron, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Granisetron, also provides the revenue of main regions and countries. Of the upcoming market potential for Granisetron, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Granisetron revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Granisetron market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Granisetron revenue, projected growth trends, production technology, application and end-user industry.
Granisetron Segment by Company
Kyowa Kirin
Teva
Sandoz
Mylan
Fresenius Kabi
Wockhardt
Taro Pharmaceutical
Natco Pharma
Hikma Pharmaceuticals
Heron Therapeutics
Dr.Reddy's
Cipla
Bluepharma
Aurobindo
APOTEX
Akorn
Granisetron Segment by Type
Injection
Transdermal system
Oral
Granisetron Segment by Application
Chemotherapy
Post operative
Granisetron Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granisetron market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Granisetron and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granisetron.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Granisetron in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Granisetron company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Granisetron revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
- Market Overview
- Product Definition
- Granisetron Market by Type
- Global Granisetron Market Size by Type, 2020 VS 2024 VS 2031
- Injection
- Transdermal system
- Oral
- Granisetron Market by Application
- Global Granisetron Market Size by Application, 2020 VS 2024 VS 2031
- Chemotherapy
- Post operative
- Assumptions and Limitations
- Study Goals and Objectives
- Granisetron Market Dynamics
- Granisetron Industry Trends
- Granisetron Industry Drivers
- Granisetron Industry Opportunities and Challenges
- Granisetron Industry Restraints
- Global Growth Perspective
- Global Granisetron Market Perspective (2020-2031)
- Global Granisetron Growth Trends by Region
- Global Granisetron Market Size by Region: 2020 VS 2024 VS 2031
- Global Granisetron Market Size by Region (2020-2025)
- Global Granisetron Market Size by Region (2026-2031)
- Competitive Landscape by Players
- Global Granisetron Revenue by Players
- Global Granisetron Revenue by Players (2020-2025)
- Global Granisetron Revenue Market Share by Players (2020-2025)
- Global Granisetron Players Revenue Share Top 10 and Top 5 in 2024
- Global Granisetron Key Players Ranking, 2023 VS 2024 VS 2025
- Global Granisetron Key Players Headquarters & Area Served
- Global Granisetron Players, Product Type & Application
- Global Granisetron Players Establishment Date
- Market Competitive Analysis
- Global Granisetron Market CR5 and HHI
- 2024 Granisetron Tier 1, Tier 2, and Tier 3
- Global Granisetron Revenue by Players
- Granisetron Market Size by Type
- Global Granisetron Revenue by Type (2020 VS 2024 VS 2031)
- Global Granisetron Revenue by Type (2020-2031)
- Global Granisetron Revenue Market Share by Type (2020-2031)
- Granisetron Market Size by Application
- Global Granisetron Revenue by Application (2020 VS 2024 VS 2031)
- Global Granisetron Revenue by Application (2020-2031)
- Global Granisetron Revenue Market Share by Application (2020-2031)
- Company Profiles
- Kyowa Kirin
- Kyowa Kirin Comapny Information
- Kyowa Kirin Business Overview
- Kyowa Kirin Granisetron Revenue and Gross Margin (2020-2025)
- Kyowa Kirin Granisetron Product Portfolio
- Kyowa Kirin Recent Developments
- Teva
- Teva Comapny Information
- Teva Business Overview
- Teva Granisetron Revenue and Gross Margin (2020-2025)
- Teva Granisetron Product Portfolio
- Teva Recent Developments
- Sandoz
- Sandoz Comapny Information
- Sandoz Business Overview
- Sandoz Granisetron Revenue and Gross Margin (2020-2025)
- Sandoz Granisetron Product Portfolio
- Sandoz Recent Developments
- Mylan
- Mylan Comapny Information
- Mylan Business Overview
- Mylan Granisetron Revenue and Gross Margin (2020-2025)
- Mylan Granisetron Product Portfolio
- Mylan Recent Developments
- Fresenius Kabi
- Fresenius Kabi Comapny Information
- Fresenius Kabi Business Overview
- Fresenius Kabi Granisetron Revenue and Gross Margin (2020-2025)
- Fresenius Kabi Granisetron Product Portfolio
- Fresenius Kabi Recent Developments
- Wockhardt
- Wockhardt Comapny Information
- Wockhardt Business Overview
- Wockhardt Granisetron Revenue and Gross Margin (2020-2025)
- Wockhardt Granisetron Product Portfolio
- Wockhardt Recent Developments
- Taro Pharmaceutical
- Taro Pharmaceutical Comapny Information
- Taro Pharmaceutical Business Overview
- Taro Pharmaceutical Granisetron Revenue and Gross Margin (2020-2025)
- Taro Pharmaceutical Granisetron Product Portfolio
- Taro Pharmaceutical Recent Developments
- Natco Pharma
- Natco Pharma Comapny Information
- Natco Pharma Business Overview
- Natco Pharma Granisetron Revenue and Gross Margin (2020-2025)
- Natco Pharma Granisetron Product Portfolio
- Natco Pharma Recent Developments
- Hikma Pharmaceuticals
- Hikma Pharmaceuticals Comapny Information
- Hikma Pharmaceuticals Business Overview
- Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (2020-2025)
- Hikma Pharmaceuticals Granisetron Product Portfolio
- Hikma Pharmaceuticals Recent Developments
- Heron Therapeutics
- Heron Therapeutics Comapny Information
- Heron Therapeutics Business Overview
- Heron Therapeutics Granisetron Revenue and Gross Margin (2020-2025)
- Heron Therapeutics Granisetron Product Portfolio
- Heron Therapeutics Recent Developments
- Dr.Reddy's
- Dr.Reddy's Comapny Information
- Dr.Reddy's Business Overview
- Dr.Reddy's Granisetron Revenue and Gross Margin (2020-2025)
- Dr.Reddy's Granisetron Product Portfolio
- Dr.Reddy's Recent Developments
- Cipla
- Cipla Comapny Information
- Cipla Business Overview
- Cipla Granisetron Revenue and Gross Margin (2020-2025)
- Cipla Granisetron Product Portfolio
- Cipla Recent Developments
- Bluepharma
- Bluepharma Comapny Information
- Bluepharma Business Overview
- Bluepharma Granisetron Revenue and Gross Margin (2020-2025)
- Bluepharma Granisetron Product Portfolio
- Bluepharma Recent Developments
- Aurobindo
- Aurobindo Comapny Information
- Aurobindo Business Overview
- Aurobindo Granisetron Revenue and Gross Margin (2020-2025)
- Aurobindo Granisetron Product Portfolio
- Aurobindo Recent Developments
- APOTEX
- APOTEX Comapny Information
- APOTEX Business Overview
- APOTEX Granisetron Revenue and Gross Margin (2020-2025)
- APOTEX Granisetron Product Portfolio
- APOTEX Recent Developments
- Akorn
- Akorn Comapny Information
- Akorn Business Overview
- Akorn Granisetron Revenue and Gross Margin (2020-2025)
- Akorn Granisetron Product Portfolio
- Akorn Recent Developments
- Kyowa Kirin
- North America
- North America Granisetron Revenue (2020-2031)
- North America Granisetron Revenue by Type (2020-2031)
- North America Granisetron Revenue by Type (2020-2025)
- North America Granisetron Revenue by Type (2026-2031)
- North America Granisetron Revenue Share by Type (2020-2031)
- North America Granisetron Revenue by Application (2020-2031)
- North America Granisetron Revenue by Application (2020-2025)
- North America Granisetron Revenue by Application (2026-2031)
- North America Granisetron Revenue Share by Application (2020-2031)
- North America Granisetron Revenue by Country
- North America Granisetron Revenue by Country (2020 VS 2024 VS 2031)
- North America Granisetron Revenue by Country (2020-2025)
- North America Granisetron Revenue by Country (2026-2031)
- United States
- Canada
- Mexico
- Europe
- Europe Granisetron Revenue (2020-2031)
- Europe Granisetron Revenue by Type (2020-2031)
- Europe Granisetron Revenue by Type (2020-2025)
- Europe Granisetron Revenue by Type (2026-2031)
- Europe Granisetron Revenue Share by Type (2020-2031)
- Europe Granisetron Revenue by Application (2020-2031)
- Europe Granisetron Revenue by Application (2020-2025)
- Europe Granisetron Revenue by Application (2026-2031)
- Europe Granisetron Revenue Share by Application (2020-2031)
- Europe Granisetron Revenue by Country
- Europe Granisetron Revenue by Country (2020 VS 2024 VS 2031)
- Europe Granisetron Revenue by Country (2020-2025)
- Europe Granisetron Revenue by Country (2026-2031)
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- China
- China Granisetron Revenue (2020-2031)
- China Granisetron Revenue by Type (2020-2031)
- China Granisetron Revenue by Type (2020-2025)
- China Granisetron Revenue by Type (2026-2031)
- China Granisetron Revenue Share by Type (2020-2031)
- China Granisetron Revenue by Application (2020-2031)
- China Granisetron Revenue by Application (2020-2025)
- China Granisetron Revenue by Application (2026-2031)
- China Granisetron Revenue Share by Application (2020-2031)
- Asia (Excluding China)
- Asia Granisetron Revenue (2020-2031)
- Asia Granisetron Revenue by Type (2020-2031)
- Asia Granisetron Revenue by Type (2020-2025)
- Asia Granisetron Revenue by Type (2026-2031)
- Asia Granisetron Revenue Share by Type (2020-2031)
- Asia Granisetron Revenue by Application (2020-2031)
- Asia Granisetron Revenue by Application (2020-2025)
- Asia Granisetron Revenue by Application (2026-2031)
- Asia Granisetron Revenue Share by Application (2020-2031)
- Asia Granisetron Revenue by Country
- Asia Granisetron Revenue by Country (2020 VS 2024 VS 2031)
- Asia Granisetron Revenue by Country (2020-2025)
- Asia Granisetron Revenue by Country (2026-2031)
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America, Middle East and Africa
- SAMEA Granisetron Revenue (2020-2031)
- SAMEA Granisetron Revenue by Type (2020-2031)
- SAMEA Granisetron Revenue by Type (2020-2025)
- SAMEA Granisetron Revenue by Type (2026-2031)
- SAMEA Granisetron Revenue Share by Type (2020-2031)
- SAMEA Granisetron Revenue by Application (2020-2031)
- SAMEA Granisetron Revenue by Application (2020-2025)
- SAMEA Granisetron Revenue by Application (2026-2031)
- SAMEA Granisetron Revenue Share by Application (2020-2031)
- SAMEA Granisetron Revenue by Country
- SAMEA Granisetron Revenue by Country (2020 VS 2024 VS 2031)
- SAMEA Granisetron Revenue by Country (2020-2025)
- SAMEA Granisetron Revenue by Country (2026-2031)
- Brazil
- Argentina
- Chile
- Colombia
- Peru
- Saudi Arabia
- Israel
- UAE
- Turkey
- Iran
- Egypt
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
- Disclaimer
List of Tables
| Table 1 | :Global Granisetron Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031 |
| Table 2 | :Injection Major Player |
| Table 3 | :Transdermal system Major Player |
| Table 4 | :Oral Major Player |
| Table 5 | :Global Granisetron Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031 |
| Table 6 | :Chemotherapy Major Player |
| Table 7 | :Post operative Major Player |
| Table 8 | :Granisetron Industry Trends |
| Table 9 | :Granisetron Industry Drivers |
| Table 10 | :Granisetron Industry Opportunities and Challenges |
| Table 11 | :Granisetron Industry Restraints |
| Table 12 | :Global Granisetron Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031 |
| Table 13 | :Global Granisetron Market Size by Region (2020-2025) & (US$ Million) |
| Table 14 | :Global Granisetron Market Share by Region (2020-2025) |
| Table 15 | :Global Granisetron Market Size by Region (2026-2031) & (US$ Million) |
| Table 16 | :Global Granisetron Market Share by Region (2026-2031) |
| Table 17 | :Global Granisetron Revenue by Players (US$ Million) & (2020-2025) |
| Table 18 | :Global Granisetron Revenue Market Share by Players (2020-2025) |
| Table 19 | :Global Granisetron Key Players Ranking, 2023 VS 2024 VS 2025 |
| Table 20 | :Global Granisetron Key Players Headquarters & Area Served |
| Table 21 | :Global Granisetron Players, Product Type & Application |
| Table 22 | :Global Granisetron Players Establishment Date |
| Table 23 | :Global Players Market Concentration Ratio (CR5 and HHI) |
| Table 24 | :Global Granisetron by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024) |
| Table 25 | :Global Granisetron Revenue by Type 2020 VS 2024 VS 2031 (US$ Million) |
| Table 26 | :Global Granisetron Revenue by Type (2020-2025) & (US$ Million) |
| Table 27 | :Global Granisetron Revenue by Type (2026-2031) & (US$ Million) |
| Table 28 | :Global Granisetron Revenue Market Share by Type (2020-2025) & (US$ Million) |
| Table 29 | :Global Granisetron Revenue Market Share by Type (2026-2031) & (US$ Million) |
| Table 30 | :Global Granisetron Revenue by Application 2020 VS 2024 VS 2031 (US$ Million) |
| Table 31 | :Global Granisetron Revenue by Application (2020-2025) & (US$ Million) |
| Table 32 | :Global Granisetron Revenue by Application (2026-2031) & (US$ Million) |
| Table 33 | :Global Granisetron Revenue Market Share by Application (2020-2025) & (US$ Million) |
| Table 34 | :Global Granisetron Revenue Market Share by Application (2026-2031) & (US$ Million) |
| Table 35 | :Kyowa Kirin Company Information |
| Table 36 | :Kyowa Kirin Business Overview |
| Table 37 | :Kyowa Kirin Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 38 | :Kyowa Kirin Granisetron Product Portfolio |
| Table 39 | :Kyowa Kirin Recent Development |
| Table 40 | :Teva Company Information |
| Table 41 | :Teva Business Overview |
| Table 42 | :Teva Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 43 | :Teva Granisetron Product Portfolio |
| Table 44 | :Teva Recent Development |
| Table 45 | :Sandoz Company Information |
| Table 46 | :Sandoz Business Overview |
| Table 47 | :Sandoz Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 48 | :Sandoz Granisetron Product Portfolio |
| Table 49 | :Sandoz Recent Development |
| Table 50 | :Mylan Company Information |
| Table 51 | :Mylan Business Overview |
| Table 52 | :Mylan Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 53 | :Mylan Granisetron Product Portfolio |
| Table 54 | :Mylan Recent Development |
| Table 55 | :Fresenius Kabi Company Information |
| Table 56 | :Fresenius Kabi Business Overview |
| Table 57 | :Fresenius Kabi Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 58 | :Fresenius Kabi Granisetron Product Portfolio |
| Table 59 | :Fresenius Kabi Recent Development |
| Table 60 | :Wockhardt Company Information |
| Table 61 | :Wockhardt Business Overview |
| Table 62 | :Wockhardt Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 63 | :Wockhardt Granisetron Product Portfolio |
| Table 64 | :Wockhardt Recent Development |
| Table 65 | :Taro Pharmaceutical Company Information |
| Table 66 | :Taro Pharmaceutical Business Overview |
| Table 67 | :Taro Pharmaceutical Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 68 | :Taro Pharmaceutical Granisetron Product Portfolio |
| Table 69 | :Taro Pharmaceutical Recent Development |
| Table 70 | :Natco Pharma Company Information |
| Table 71 | :Natco Pharma Business Overview |
| Table 72 | :Natco Pharma Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 73 | :Natco Pharma Granisetron Product Portfolio |
| Table 74 | :Natco Pharma Recent Development |
| Table 75 | :Hikma Pharmaceuticals Company Information |
| Table 76 | :Hikma Pharmaceuticals Business Overview |
| Table 77 | :Hikma Pharmaceuticals Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 78 | :Hikma Pharmaceuticals Granisetron Product Portfolio |
| Table 79 | :Hikma Pharmaceuticals Recent Development |
| Table 80 | :Heron Therapeutics Company Information |
| Table 81 | :Heron Therapeutics Business Overview |
| Table 82 | :Heron Therapeutics Granisetron Revenue and Gross Margin (US$ Million) & (2020-2025) |
| Table 83 | :Heron Therapeutics Granisetron Product Portfolio |
| Table 84 | :Heron Therapeutics Recent Development |
| Table 85 | :Dr.Reddy's Company Information |
| Table 86 | :Dr.Reddy's Business Overview |
| Table 87 | :Dr.Reddy's Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025) |
| Table 88 | :Dr.Reddy's Granisetron Product Portfolio |
| Table 89 | :Dr.Reddy's Recent Development |
| Table 90 | :Cipla Company Information |
| Table 91 | :Cipla Business Overview |
| Table 92 | :Cipla Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025) |
| Table 93 | :Cipla Granisetron Product Portfolio |
| Table 94 | :Cipla Recent Development |
| Table 95 | :Bluepharma Company Information |
| Table 96 | :Bluepharma Business Overview |
| Table 97 | :Bluepharma Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025) |
| Table 98 | :Bluepharma Granisetron Product Portfolio |
| Table 99 | :Bluepharma Recent Development |
| Table 100 | :Aurobindo Company Information |
| Table 101 | :Aurobindo Business Overview |
| Table 102 | :Aurobindo Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025) |
| Table 103 | :Aurobindo Granisetron Product Portfolio |
| Table 104 | :Aurobindo Recent Development |
| Table 105 | :APOTEX Company Information |
| Table 106 | :APOTEX Business Overview |
| Table 107 | :APOTEX Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025) |
| Table 108 | :APOTEX Granisetron Product Portfolio |
| Table 109 | :APOTEX Recent Development |
| Table 110 | :Akorn Company Information |
| Table 111 | :Akorn Business Overview |
| Table 112 | :Akorn Granisetron Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2020-2025) |
| Table 113 | :Akorn Granisetron Product Portfolio |
| Table 114 | :Akorn Recent Development |
| Table 115 | :North America Granisetron Revenue by Type (2020-2025) & (US$ Million) |
| Table 116 | :North America Granisetron Revenue by Application (2020-2025) & (US$ Million) |
| Table 117 | :North America Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 118 | :North America Granisetron Revenue by Country (2020-2025) & (US$ Million) |
| Table 119 | :North America Granisetron Revenue by Country (2026-2031) & (US$ Million) |
| Table 120 | :Europe Granisetron Revenue by Type (2020-2025) & (US$ Million) |
| Table 121 | :Europe Granisetron Revenue by Application (2020-2025) & (US$ Million) |
| Table 122 | :Europe Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 123 | :Europe Granisetron Revenue by Country (2020-2025) & (US$ Million) |
| Table 124 | :Europe Granisetron Revenue by Country (2026-2031) & (US$ Million) |
| Table 125 | :China Granisetron Revenue by Type (2020-2025) & (US$ Million) |
| Table 126 | :China Granisetron Revenue by Application (2020-2025) & (US$ Million) |
| Table 127 | :Asia Granisetron Revenue by Type (2020-2025) & (US$ Million) |
| Table 128 | :Asia Granisetron Revenue by Application (2020-2025) & (US$ Million) |
| Table 129 | :Asia Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 130 | :Asia Granisetron Revenue by Country (2020-2025) & (US$ Million) |
| Table 131 | :Asia Granisetron Revenue by Country (2026-2031) & (US$ Million) |
| Table 132 | :SAMEA Granisetron Revenue by Type (2020-2025) & (US$ Million) |
| Table 133 | :SAMEA Granisetron Revenue by Application (2020-2025) & (US$ Million) |
| Table 134 | :SAMEA Granisetron Revenue by Country (2020 VS 2024 VS 2031) & (US$ Million) |
| Table 135 | :SAMEA Granisetron Revenue by Country (2020-2025) & (US$ Million) |
| Table 136 | :SAMEA Granisetron Revenue by Country (2026-2031) & (US$ Million) |
| Table 137 | :Research Programs/Design for This Report |
| Table 138 | :Authors List of This Report |
| Table 139 | :Secondary Sources |
| Table 140 | :Primary Sources |
List of Figures
| Figure 1 | :Granisetron Image |
| Figure 2 | :Global Granisetron Market Size Growth Rate by Type (US$ Million), 2020 VS 2024 VS 2031 |
| Figure 3 | :Global Granisetron Market Size Share 2020 VS 2024 VS 2031 |
| Figure 4 | :Injection Image |
| Figure 5 | :Transdermal system Image |
| Figure 6 | :Oral Image |
| Figure 7 | :Global Granisetron Market Size Growth Rate by Application (US$ Million), 2020 VS 2024 VS 2031 |
| Figure 8 | :Global Granisetron Market Size Share 2020 VS 2024 VS 2031 |
| Figure 9 | :Chemotherapy Image |
| Figure 10 | :Post operative Image |
| Figure 11 | :Global Granisetron Market Size (US$ Million) & (2020-2031) |
| Figure 12 | :Global Granisetron Market Size, (US$ Million), 2020 VS 2024 VS 2031 |
| Figure 13 | :Global Granisetron Market Share by Region: 2020 VS 2024 VS 2031 |
| Figure 14 | :Global Granisetron Players Revenue Share Top 10 and Top 5 in 2024 |
| Figure 15 | :Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024 |
| Figure 16 | :Global Granisetron Revenue by Type (2020 VS 2024 VS 2031) & (US$ Million) |
| Figure 17 | :Global Granisetron Revenue Market Share 2020 VS 2024 VS 2031 |
| Figure 18 | :Global Granisetron Revenue Market Share by Type (2020-2031) |
| Figure 19 | :Global Granisetron Revenue by Application (2020 VS 2024 VS 2031) & (US$ Million) |
| Figure 20 | :Global Granisetron Revenue Market Share by Application (2020 VS 2024 VS 2031) |
| Figure 21 | :Global Granisetron Revenue Market Share by Application (2020-2031) |
| Figure 22 | :North America Granisetron Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 23 | :North America Granisetron Revenue by Type (2026-2031) & (US$ Million) |
| Figure 24 | :North America Granisetron Revenue Share by Type (2020-2031) |
| Figure 25 | :North America Granisetron Revenue by Application (2026-2031) & (US$ Million) |
| Figure 26 | :North America Granisetron Revenue Share by Application (2020-2031) |
| Figure 27 | :North America Granisetron Revenue Share by Country (2020-2031) |
| Figure 28 | :United States Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 29 | :Canada Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 30 | :Mexico Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 31 | :Europe Granisetron Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 32 | :Europe Granisetron Revenue by Type (2026-2031) & (US$ Million) |
| Figure 33 | :Europe Granisetron Revenue Share by Type (2020-2031) |
| Figure 34 | :Europe Granisetron Revenue by Application (2026-2031) & (US$ Million) |
| Figure 35 | :Europe Granisetron Revenue Share by Application (2020-2031) |
| Figure 36 | :Europe Granisetron Revenue Share by Country (2020-2031) |
| Figure 37 | :Germany Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 38 | :France Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 39 | :U.K. Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 40 | :Italy Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 41 | :Spain Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 42 | :Russia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 43 | :Netherlands Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 44 | :Nordic Countries Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 45 | :China Granisetron Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 46 | :China Granisetron Revenue by Type (2026-2031) & (US$ Million) |
| Figure 47 | :China Granisetron Revenue Share by Type (2020-2031) |
| Figure 48 | :China Granisetron Revenue by Application (2026-2031) & (US$ Million) |
| Figure 49 | :China Granisetron Revenue Share by Application (2020-2031) |
| Figure 50 | :Asia Granisetron Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 51 | :Asia Granisetron Revenue by Type (2026-2031) & (US$ Million) |
| Figure 52 | :Asia Granisetron Revenue Share by Type (2020-2031) |
| Figure 53 | :Asia Granisetron Revenue by Application (2026-2031) & (US$ Million) |
| Figure 54 | :Asia Granisetron Revenue Share by Application (2020-2031) |
| Figure 55 | :Asia Granisetron Revenue Share by Country (2020-2031) |
| Figure 56 | :Japan Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 57 | :South Korea Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 58 | :India Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 59 | :Australia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 60 | :Taiwan Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 61 | :Southeast Asia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 62 | :SAMEA Granisetron Revenue YoY Growth (2020-2031) & (US$ Million) |
| Figure 63 | :SAMEA Granisetron Revenue by Type (2026-2031) & (US$ Million) |
| Figure 64 | :SAMEA Granisetron Revenue Share by Type (2020-2031) |
| Figure 65 | :SAMEA Granisetron Revenue by Application (2026-2031) & (US$ Million) |
| Figure 66 | :SAMEA Granisetron Revenue Share by Application (2020-2031) |
| Figure 67 | :SAMEA Granisetron Revenue Share by Country (2020-2031) |
| Figure 68 | :Brazil Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 69 | :Argentina Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 70 | :Chile Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 71 | :Colombia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 72 | :Peru Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 73 | :Saudi Arabia Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 74 | :Israel Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 75 | :UAE Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 76 | :Turkey Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 77 | :Iran Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 78 | :Egypt Granisetron Revenue YoY Growth (US$ Million) & (2020-2031) |
| Figure 79 | :Years Considered |
| Figure 80 | :Research Process |
| Figure 81 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Pharma & Healthcare
Global Granisetron Market Analysis and Forecast 2025-2031
Pages: 203
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.